Dr. Lal Pathlabs (LALPATHLAB) Share Price rises near 52-week high as stock trades at Rs 1,996.70
- October 1, 2026
- Posted by: Chaitanya Auti
- Category: News
Dr. Lal Pathlabs Share Price is trading at Rs 1,996.70, up 3.32% from the previous close of Rs 1,932.60, and is moving close to its 52-week high during the morning session on 12 October 2026 at 11:22 AM IST. The company’s market capitalisation stands at Rs 32,438.46 crore. This Dr. Lal Pathlabs Share Price move is relevant because it places the stock near a yearly high while leaving the latest Univest data to confirm the price event without establishing any company-specific catalyst.
The Dr. Lal Pathlabs Share Price move also keeps Dr. Lal Pathlabs Share Price Today, Dr. Lal Pathlabs Stock News and Dr. Lal Pathlabs Share Price Update in focus for readers tracking healthcare stocks in the Indian Stock Market. The latest quote shows a day range of Rs 1,939.40 to Rs 2,002.85, with the stock opening at Rs 1,952.90. As the price stays near the 52-week peak, the market is watching the latest Dr. Lal Pathlabs Share Price action alongside company fundamentals and sector benchmarks.
Dr. Lal Pathlabs Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,996.7 |
| Previous Close | Rs 1,932.6 |
| Today's Move | +Rs 64.1 (+3.32%) |
| Open | Rs 1,952.9 |
| High | Rs 2,002.85 |
| Low | Rs 1,939.4 |
| Market Capitalisation | Rs 32,438.46 crore |
Dr. Lal Pathlabs Ltd. (LALPATHLAB) traded at Rs 1,996.7 versus the previous close of Rs 1,932.6, a rise of 3.32%. The stock opened at Rs 1,952.9, reached a high of Rs 2,002.85 and touched a low of Rs 1,939.4.
Dr. Lal Pathlabs Share Price Today shows a move of Rs 64.10 above the previous close, with the stock trading at Rs 1,996.70 versus Rs 1,932.60 earlier. The session opened at Rs 1,952.90, touched Rs 1,939.40 on the low side and Rs 2,002.85 on the high side, leaving the quote close to the one-year high. Since the stock is near its 52-week high, Dr. Lal Pathlabs Share Price News remains centred on a simple price check: the move is visible in the near-peak location, while the latest Univest figures do not establish a company-specific reason. That makes Dr. Lal Pathlabs Share Price a live market watch item for investors following share market today headlines. The next section turns to company fundamentals and valuation context.
Dr. Lal Pathlabs Ltd. (LALPATHLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 32,438.46 crore |
| P/E Ratio | 59.86x |
| P/B Ratio | 12.41x |
| ROE | 22.37% |
| ROCE | 29.56% |
| EPS | Rs 32.29 |
| Book Value Per Share | Rs 155.67 |
| Dividend Yield | 1.06% |
Dr. Lal Pathlabs Ltd. (LALPATHLAB) fundamental metrics show P/E 59.86x, P/B 12.41x, ROE 22.37%, ROCE 29.56%. These figures provide context only and are not a buy or sell signal.
Dr. Lal Pathlabs Ltd. has a market capitalisation of Rs 32,438.46 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 59.86x, P/B at 12.41x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 22.37% and ROCE of 29.56%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 32.29, book value per share of Rs 155.67, dividend yield of 1.06%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 38.95x, median ROE of 12.77%, median ROCE of 15.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 59.86x |
| Benchmark Median P/E | 38.95x |
| Benchmark Average P/E | 86.11x |
| Benchmark P/E Range | 0x to 1,589.53x |
| Company P/B Ratio | 12.41x |
| Benchmark Median P/B | 3.27x |
| Company ROE | 22.37% |
| Benchmark Median ROE | 12.77% |
| Company ROCE | 29.56% |
| Benchmark Median ROCE | 15.61% |
| Company Market Capitalisation | Rs 32,438.46 crore |
| Benchmark Median Market Cap | Rs 449.19 crore |
Dr. Lal Pathlabs Ltd. (LALPATHLAB) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.
Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a P/E ratio of 59.86x, which is above the benchmark median of 38.95x, a difference of +53.68%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a ROE of 22.37%, which is above the benchmark median of 12.77%, a difference of +75.18%. Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a ROCE of 29.56%, which is above the benchmark median of 15.61%, a difference of +89.37%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Narayana Hrudayalaya Ltd. | NH | 35,140.86 | 43.06 | 7.4 | 19.86 | 16.2 |
| Global Health Ltd. | MEDANTA | 35,327.46 | 63.52 | 8.59 | 15.12 | 19.38 |
| Krishna Institute of Medical Sciences Ltd | KIMS | 29,602.06 | 144.9 | 7.82 | 11.04 | 11.51 |
| Fortis Healthcare Ltd. | FORTIS | 59,271.76 | 56.56 | 5.83 | 11.32 | 14.07 |
| Aster DM Healthcare Ltd. | ASTERDM | 61,012.71 | 191.45 | 14.42 | 13.07 | 16.22 |
Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a P/E ratio of 59.86x compared with the displayed peer median of 63.52x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 22.37% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 29.56% versus the displayed peer median of 16.2%, providing a capital-efficiency comparison. Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a market capitalisation of Rs 32,438.46 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching Dr. Lal Pathlabs
- Dr. Lal Pathlabs Share Price is trading at Rs 1,996.70, above the previous close of Rs 1,932.60.
- The stock is near its 52-week high, with an intraday high of Rs 2,002.85.
- Market capitalisation stands at Rs 32,438.46 crore.
- P/E is 59.86 and P/B is 12.41, compared with the same-industry median of 38.95 and 3.27.
- ROE of 22.37% and ROCE of 29.56% are above the same-industry medians of 12.77% and 15.61%.
About Dr. Lal Pathlabs
Dr. Lal Pathlabs Ltd. operates in the Healthcare sector and the Hospital & Healthcare Services industry. For Dr. Lal Pathlabs Share Price readers, the company profile matters because the stock is being tracked within a diagnostics and healthcare-services context rather than in an unrelated business category. Univest follows Dr. Lal Pathlabs Company News, Dr. Lal Pathlabs Market Cap and Dr. Lal Pathlabs Share Price Update so readers can place the current quote alongside the company’s core financial metrics and sector positioning.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Dr. Lal Pathlabs Share Price in focus today?
Ans. Dr. Lal Pathlabs Share Price is in focus because it is trading at Rs 1,996.70, up 3.32% from the previous close, and is moving near its 52-week high during the current session.
What is Dr. Lal Pathlabs Share Price today?
Ans. Dr. Lal Pathlabs Share Price today is Rs 1,996.70. The stock opened at Rs 1,952.90 and traded between Rs 1,939.40 and Rs 2,002.85 in the session so far.
How far is Dr. Lal Pathlabs Share Price from its 52-week high?
Ans. Dr. Lal Pathlabs Share Price is trading close to its 52-week high, with the day’s high at Rs 2,002.85 and the current price at Rs 1,996.70. That keeps the stock near its yearly high zone.
What does Dr. Lal Pathlabs Share Price valuation show?
Ans. Dr. Lal Pathlabs Share Price carries a P/E of 59.86 and a P/B of 12.41. Both are well above the same-industry median, which shows a richer valuation than the benchmark group.
What are the key fundamentals behind Dr. Lal Pathlabs Share Price?
Ans. Dr. Lal Pathlabs Share Price is supported by ROE of 22.37%, ROCE of 29.56%, EPS of Rs 32.29, book value of Rs 155.67 and dividend yield of 1.06%, along with revenue of Rs 797.7 crore for Jun 2026.
How does Dr. Lal Pathlabs Share Price compare with peers?
Ans. Dr. Lal Pathlabs Share Price has a higher P/E than Narayana Hrudayalaya and Fortis Healthcare in the listed peer set. Its ROE and ROCE are also higher than each of those peers shown here.
What sector does Dr. Lal Pathlabs Share Price belong to?
Ans. Dr. Lal Pathlabs Share Price belongs to the Healthcare sector and the Hospital & Healthcare Services industry. The same-industry benchmark includes 66 companies, which helps frame its valuation and return ratios.
What market capitalisation is associated with Dr. Lal Pathlabs Share Price?
Ans. Dr. Lal Pathlabs Share Price is associated with a market capitalisation of Rs 32,438.46 crore. That places it well above the benchmark median for the same industry group.
Track Dr. Lal Pathlabs Share Price on Univest
Use Dr. Lal Pathlabs Ltd. (LALPATHLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
You can track Dr. Lal Pathlabs Share Price on Univest for live price updates, share price news, market capitalisation, valuation ratios, 52-week levels, company financials and sector comparison. Univest also helps readers follow Dr. Lal Pathlabs Stock Analysis, Dr. Lal Pathlabs Fundamental Analysis and Dr. Lal Pathlabs Share Price Live in one place.